loadpatents
name:-0.041136026382446
name:-0.034918069839478
name:-0.0099279880523682
Zhao; Yufen Patent Filings

Zhao; Yufen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhao; Yufen.The latest application filed is for "cyclic dinucleotides as anticancer agents".

Company Profile
8.30.34
  • Zhao; Yufen - Pennington NJ
  • Zhao; Yufen - Xiamen City CN
  • Zhao; Yufen - Beijing CN
  • Zhao; Yufen - Xiamen Fujian 361005 CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cyclic dinucleotides as anticancer agents
Grant 11,427,610 - Fink , et al. August 30, 2
2022-08-30
Cyclic dinucleotides as anticancer agents
Grant 11,339,185 - Fink , et al. May 24, 2
2022-05-24
Cyclic Dinucleotides As Anticancer Agents
App 20220117995 - FINK; Brian E. ;   et al.
2022-04-21
Cyclic Dinucleotides As Anticancer Agents
App 20210253624 - FINK; Brian E. ;   et al.
2021-08-19
Ophthalmic Pharmaceutical Composition, Preparation Method Therefor And Application Thereof
App 20210030833 - Liu; Zuguo ;   et al.
2021-02-04
Cyclic dinucleotides as anticancer agents
Grant 10,744,150 - Fink , et al. A
2020-08-18
Automatic high-speed rotary atomizing device and a fire extinguishing method by using the same
Grant 10,632,413 - Yin , et al.
2020-04-28
Cyclic Dinucleotides As Anticancer Agents
App 20200079815 - FINK; Brian E. ;   et al.
2020-03-12
Cyclic dinucleotides as anticancer agents
Grant 10,519,187 - Fink , et al. Dec
2019-12-31
Cyclic Dinucleotides As Anticancer Agents
App 20190248828 - Fink; Brian E. ;   et al.
2019-08-15
Cyclic Dinucleotides As Anticancer Agents
App 20190030057 - FINK; Brian E. ;   et al.
2019-01-31
TGF.beta.R antagonists
Grant 9,708,316 - Fink , et al. July 18, 2
2017-07-18
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 9,556,178 - Purandare , et al. January 31, 2
2017-01-31
An Automatic High-speed Rotary Atomizing Device And A Fire Extinguishing Method By Using The Same
App 20160367931 - YIN; Yingwu ;   et al.
2016-12-22
Carbazole compounds useful as bromodomain inhibitors
Grant 9,492,460 - Poss , et al. November 15, 2
2016-11-15
Tgf Beta R Antagonists
App 20160176871 - Fink; Brian E. ;   et al.
2016-06-23
Imidazopyridazinecarbonitriles useful as kinase inhibitors
Grant 9,371,328 - Fink , et al. June 21, 2
2016-06-21
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20160108050 - Purandare; Ashok Vinayak ;   et al.
2016-04-21
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 9,273,057 - Purandare , et al. March 1, 2
2016-03-01
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
Grant 9,273,014 - Gavai , et al. March 1, 2
2016-03-01
Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
Grant 9,242,941 - Gavai , et al. January 26, 2
2016-01-26
Alkyl, Fluoroalkyl-1,4-benzodiazepinone Compounds
App 20150239851 - Gavai; Ashvinikumar V. ;   et al.
2015-08-27
Fluoroalkyl And Fluorocycloalkyl 1,4-benzodiazepinone Compounds
App 20150231152 - Zhao; Yufen ;   et al.
2015-08-20
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20150210697 - Purandare; Ashok Vinayak ;   et al.
2015-07-30
Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof
App 20150166489 - Gavai; Ashvinikumar V. ;   et al.
2015-06-18
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
Grant 8,999,918 - Gavai , et al. April 7, 2
2015-04-07
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20150065465 - Purandare; Ashok Vinayak ;   et al.
2015-03-05
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 8,940,736 - Purandare , et al. January 27, 2
2015-01-27
Carbazole Compounds Useful As Bromodomain Inhibitors
App 20140256700 - Poss; Michael A. ;   et al.
2014-09-11
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20140179674 - Fink; Brian E. ;   et al.
2014-06-26
Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof
App 20140087992 - Gavai; Ashvinikumar V. ;   et al.
2014-03-27
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20140018319 - Purandare; Ashok Vinayak ;   et al.
2014-01-16
Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
Grant 8,466,171 - Shan , et al. June 18, 2
2013-06-18
Substituted imidazopyridazines useful as kinase inhibitors
Grant 8,389,527 - Fink , et al. March 5, 2
2013-03-05
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20120283241 - Fink; Brian E. ;   et al.
2012-11-08
Imidazopyridazinecarbonitriles useful as kinase inhibitors
Grant 8,252,795 - Fink , et al. August 28, 2
2012-08-28
Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
Grant 8,067,582 - Norris , et al. November 29, 2
2011-11-29
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20110039838 - Fink; Brian E. ;   et al.
2011-02-17
Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function
App 20100331324 - Norris; Derek J. ;   et al.
2010-12-30
Substituted Imidazopyridazines Useful As Kinase Inhibitors
App 20100323994 - Fink; Brian E. ;   et al.
2010-12-23
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,846,931 - Fink , et al. December 7, 2
2010-12-07
Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function
App 20100256180 - Shan; Weifang ;   et al.
2010-10-07
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20100113458 - Fink; Brian E. ;   et al.
2010-05-06
Pyrrolotriazine kinase inhibitors
Grant 7,514,435 - Chen , et al. April 7, 2
2009-04-07
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20090048244 - Fink; Brian E. ;   et al.
2009-02-19
ATP competitive kinase inhibitors
Grant 7,358,256 - Gavai , et al. April 15, 2
2008-04-15
Acridone inhibitors of IMPDH enzyme
Grant 7,312,209 - Iwanowicz , et al. December 25, 2
2007-12-25
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,297,695 - Fink , et al. November 20, 2
2007-11-20
Pyrrolotriazine Kinase Inhibitors
App 20070149534 - Chen; Ping ;   et al.
2007-06-28
Synthesis method of alanylglutamine
Grant 7,163,917 - Zhao , et al. January 16, 2
2007-01-16
Pyrrolotriazine compounds
Grant 7,151,176 - Gavai , et al. December 19, 2
2006-12-19
Pyrrolotriazine compounds as kinase inhibitors
Grant 7,141,571 - Fink , et al. November 28, 2
2006-11-28
Pyrrolotriazine Compounds As Kinase Inhibitors
App 20060264438 - Fink; Brian E. ;   et al.
2006-11-23
ATP competitive kinase inhibitors
App 20060217369 - Gavai; Ashvinikumar V. ;   et al.
2006-09-28
Pyrrolotriazine compounds
App 20060089358 - Gavai; Ashvinikumar V. ;   et al.
2006-04-27
Process of producing ala-gln dipeptide
App 20050233977 - Zhao, Yufen ;   et al.
2005-10-20
Endothelin antagonist
Grant 6,953,780 - Liu , et al. October 11, 2
2005-10-11
Pyrrolotriazine compounds as kinase inhibitors
App 20050182058 - Fink, Brian E. ;   et al.
2005-08-18
Heterocyclic acridone inhibitors of IMPDH enzyme
Grant 6,916,809 - Chen , et al. July 12, 2
2005-07-12
Acridone inhibitors of IMPDH enzyme
App 20040053955 - Iwanowicz, Edwin J. ;   et al.
2004-03-18
Endothelin antagonist
App 20040038906 - Liu, Keliang ;   et al.
2004-02-26
Heterocyclic acridone inhibitors of IMPDH enzyme
App 20030181497 - Chen, Ping ;   et al.
2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed